Biarylcarboxamide inhibitors of phosphodiesterase IV and tumor necrosis factor-alpha

被引：13

作者：

Chambers, RJ

Marfat, A

Cheng, JB

Cohan, VL

Damon, DB

Duplantier, AJ

Hibbs, TA

Jenkinson, TH

Johnson, KL

Kraus, KG

Pettipher, ER

Salter, ED

Shirley, JT

Umland, JP

机构：

[1] Pfizer Central Research, Pfizer Inc., Groton

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1997年 / 7卷 / 06期

关键词：

D O I：

10.1016/S0960-894X(97)00097-8

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Tumor necrosis factor-alpha (TNF-alpha) has been implicated as a key mediator in the progression of rheumatoid arthritis. Inhibitors of phosphodiesterase IV (PDE IV) have been shown to inhibit the production of TNF-alpha by elevating intracellular levels of cyclic adenosine monophosphate (cAMP). Our efforts in a series of biarylcarboxamides have led to the identification of 8j (CP-353,164) as a potent inhibitor of PDE IV and TNF-alpha production. (C) 1997 Elsevier Science Ltd.

引用

页码：739 / 744

页数：6

共 50 条

[1] Biarylcarboxamide inhibitors of phosphodiesterase IV and tumor necrosis factor.
Chambers, RJ
Antognoli, GW
Cheng, JB
Cohan, VL
Duplantier, AJ
Hibbs, TA
Jenkinson, TH
Johnson, KL
Kraus, KG
Marfat, A
Pettipher, RE
Salter, ED
Shirley, JT
Umland, JP
Watson, JW
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 139 - MEDI
[2] Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-alpha synthesis
Greten, TF
Sinha, B
Haslberger, C
Eigler, A
Endres, S
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 299 (1-3) : 229 - 233
[3] Cutaneous pseudolymphoma induced by tumor necrosis factor-alpha inhibitors
Yokota, Masaki
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (06) : E217 - E219
[4] Bradypnea in a child taking tumor necrosis factor-alpha inhibitors
Sener, Seher
Basaran, Ozge
Bilginer, Yelda
Kiper, Nural
Ozen, Seza
PEDIATRIC PULMONOLOGY, 2022, 57 (09) : 2267 - 2268
[5] Tumor necrosis factor-alpha inhibitors and acne fulminans: Friend or foe?
Barry, Kelly K.
Neale, Holly D.
Hawryluk, Elena B.
PEDIATRIC DERMATOLOGY, 2023, 40 (04) : 678 - 680
[6] The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
Victoria Hernandez, Maria
Sanmarti, Raimon
Canete, Juan D.
EXPERT OPINION ON DRUG SAFETY, 2016, 15 (05) : 613 - 624
[7] Pharmacological modulation of myocardial tumor necrosis factor alpha production by phosphodiesterase inhibitors
Bergman, MR
Holycross, BJ
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 279 (01): : 247 - 254
[8] Nano anti-tumor necrosis factor-alpha based potentiometric sensor for tumor necrosis factor-alpha detection
Say, Ridan
Ozkutuk, Ebru Birlik
Unluer, Ozlem Bicen
Ugurag, Deniz
Ersoz, Arzu
SENSORS AND ACTUATORS B-CHEMICAL, 2015, 209 : 864 - 869
[9] Tumor necrosis factor-alpha inhibitors and alopecia : a paradoxical side-effect
Leprieur-Truet, S.
Veyrac, G.
Lecamp, C.
Jolliet, P.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 74 - 74
[10] The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis
Lee, Suhwan
Park, Yu Jeong
Lee, Joo Yong
JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (42)

← 1 2 3 4 5 →